Scientists may have finally found one reason coffee is repeatedly linked to longer life and lower disease risk — and it's not the caffeine.
Researchers at the Texas A&M College of Veterinary Medicine and Biomedical Sciences discovered that certain compounds in coffee activate NR4A1, a nuclear receptor that acts as a "nutrient sensor" protecting cells from stress-induced damage.
The study, published in the journal Nutrients, provides one of the first direct biological mechanisms explaining coffee's broad health benefits.
"Coffee has well-known health-promoting properties," said Dr. Stephen Safe, distinguished professor at Texas A&M. "What we've shown is that some of those effects may be linked to how coffee compounds interact with this receptor, which is involved in protecting the body from stress-induced damage."
NR4A1 is part of a group of nuclear receptors that help control gene activity when the body faces stress or tissue damage. Previous research has described it as a sensor that responds to dietary compounds and helps maintain healthy aging.
"If you damage almost any tissue, NR4A1 responds to bring that damage down," Safe said. "If you take that receptor away, the damage is worse."
Surprisingly, the most active compounds were not caffeine but polyhydroxy and polyphenolic compounds such as caffeic acid — substances also found in many fruits and vegetables. When the researchers removed NR4A1 from cells, the protective effects completely disappeared.
"Caffeine binds the receptor, but it doesn't do much in our models," Safe noted. "The polyhydroxy and polyphenolic compounds are much more active."
This finding may explain why large population studies have linked both caffeinated and decaffeinated coffee with similar health benefits.
The research does not change current recommendations for coffee consumption. However, it provides scientists with a long-sought biological explanation for coffee's association with better health and longevity. Safe's team is also studying synthetic compounds targeting NR4A1 more effectively, aiming to develop potential treatments for cancer and other diseases.
